Global Imipenem/Cilastatin Market Analysis by Grade, Forms, Brands, Application, Global Trends, Share & Challenges Analysis & Industry Forecast (2018-2023)

October 2018 | 100 pages | ID: GD21FB6151DEN
SPER Market Research

Abstracts

REPORT DESCRIPTION

'Imipenem/Cilastatin' is a combination drug consists of two individual drugs: Imipenem and Cilastatin Sodium in the ratio of 1:1 by weight. “Primaxin” the brand of Originator Merck & Co. contains Imipenem & Cilastatin, a new beta-lactam agent of the carbapenem class (1-Beta-methyl carbapenem). Primaxin is an antibiotic useful for the treatment of a number of bacterial infections. Imipenem/Cilastatin current market size is 5446.69 Million USD, with a CAGR of 17% for the session 2014-2017 & it is forecasted to grow with a CAGR of 23% during the session of 2018-2023. The multiple indications among all other carbapenem’s provide contribution in the market growth. Imipenem is a white or pale yellow powder & broad-spectrum beta-lactam antibiotic & Cilastatin sodium is light yellow hygroscopic, amorphous powder. 'Imipenem/Cilastatin' is off white to yellowish white hygroscopic powder. For injection formulation it is available in two forms i.e. powder & solution. It is given by injection into a vein or muscle. Primaxin (Imipenem and Cilastatin for Injectable Suspension) is a formulation of Imipenem (a thienamycin antibiotic) and Cilastatin sodium (the inhibitor of the renal dipeptidase, dehydropeptidase-I). Primaxin is a potent broad spectrum antibacterial agent for intramuscular administration.

The activity of “Imipenem/Cilastatin” against an unusually broad spectrum of pathogens makes it particularly useful in the treatment of polymicrobic mixed aerobic/anaerobic infections as well as initial therapy prior to the identification of the causative organisms. Imipenem/Cilastatin is indicated for the treatment of the following infections due to susceptible organisms;

• Intra-Abdominal Infections
• Lower Respiratory Tract Infections
• Gynaecological Infections
• Septicaemia
• Genitourinary Tract Infections
• Bone & Joint Infections
• Skin & Soft Tissue Infections
• Endocarditis

This report represents the global and regional analysis of 'Imipenem/Cilastatin' in terms of Dosage, Strength, API, application wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent wise (North America, Europe, Asia, South America, Africa & Oceania) manufacturer & consumer analysis & market share.

REPORT HIGHLIGHTS

• Provide manufacturing capacity, consumption, current & past status & also the forecasting upto 2023.
• Provide complete overview including type, application & forecast region.
• Provide complete analysis of API & formulation including brand names, strength & market overview.
• Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
• Historical, current and projected market size in terms of volume and value.
• Analyze the global & regional potential market, advantages, risk & opportunity.
• Identify significant trends and factors driving or inhibiting the market growth.
• In-depth coverage of complete market in terms of supplier, buyer, price, trend, growth & forecasting.

The report covers Imipenem/Cilastatin forms

• Imipenem/Cilastatin As Injection
• Imipenem/Cilastatin As Freeze Dried Powder

The report covers Imipenem/Cilastatin end users

• Imipenem/Cilastatin In Hospital
• Imipenem/Cilastatin In Clinic
• Imipenem/Cilastatin In Other

The report covers exhaustive analysis on;

• Market Segments
• Market Dynamics
• Brands In Market
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved
• Forecasting
• Technology

The report includes Regional analysis on;

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Europe (Germany, Italy, France, U.K, Spain & Rest of Europe)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Middle East and Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

Top Players in Imipenem/Cilastatin industry

• Merck Sharp Dohme Corp.
• Sun Pharmaceutical Industries Ltd
• Vitalis SACI

Key Questions answered by report

• What was the market size trend of 2014-2017?
• What will be the market size trend of next 4-5 years?
• What are the most common brands in terms of volume?
• How much brands available for Imipenem/Cilastatin?
• Who are the key players of Imipenem/Cilastatin API?
• What are the major application industries & emerging industries?
• Who are the key vendors present in the market?
• How the future opportunities & market drivers will affect the market dynamics & ongoing trends?
• Which one segment from global coverage will be lucrative & will grow?
• What are the main market opportunities and threats faced by the vendors?
• What are the strategies are following by the existing market players?

Contents

CHAPTER 1 RESEARCH METHODOLOGY

CHAPTER 2 REPORT DESCRIPTION

CHAPTER 3 IMIPENEM/CILASTATIN EXECUTIVE SUMMARY

CHAPTER 4 IMIPENEM/CILASTATIN BASIC HIGHLIGHTS

4.1. Product Overview
4.2. CAS No & Molecular Weight
4.3. Innovator & Developer Details
4.4. Priority & Patent Expiry
4.5. Molecular Formula
4.6. Market Status

CHAPTER 5 GLOBAL IMIPENEM/CILASTATIN PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY

5.1. Imipenem/Cilastatin Forms (Crystalline or Amorphous)
5.2. Imipenem/Cilastatin Grades Description & Variants
5.3. Imipenem/Cilastatin Route of Administration
5.4. Imipenem/Cilastatin Synonym
5.5. Imipenem/Cilastatin Forms
  5.5.1. Freeze Dried Powder
  5.5.2. Injectable
5.6. Imipenem/Cilastatin End Users
  5.6.1. Hospital
  5.6.2. Clinic
  5.6.3. Other

CHAPTER 6 IMIPENEM/CILASTATIN MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM

6.1. Imipenem/Cilastatin Manufacturing Process Routes & Flow Chart
6.2. Imipenem/Cilastatin Upstream & Downstream Products

CHAPTER 7 IMIPENEM/CILASTATIN BRAND LIST & MECHANISM OF ACTION

7.1. Imipenem/Cilastatin All Global Brands
7.2. Imipenem/Cilastatin Dosage & Their Strengths
7.3. Imipenem/Cilastatin Mechanism of Action

CHAPTER 8 IMIPENEM/CILASTATIN (API) REGION WISE MARKET OVERVIEW

8.1. Imipenem/Cilastatin Market Overview In Asia (China, India & Taiwan)

CHAPTER 9 IMIPENEM/CILASTATIN (FORMULATION) REGION WISE MARKET OVERVIEW

9.1. Imipenem/Cilastatin Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
9.2. Imipenem/Cilastatin Market Overview In Europe (Switzerland, Austria, Greece, United Kingdom & Rest of Europe Available)
9.3. Imipenem/Cilastatin Market Overview In North America (United State)
9.4. Imipenem/Cilastatin Market Overview In South America (Brazil, Argentina, Bolivia, Paraguay & Rest of South America Available)
9.5. Imipenem/Cilastatin Market Overview In Oceania (New Zealand)

CHAPTER 10 IMIPENEM/CILASTATIN (API & FORMULATION) CONTINENT & COUNTRY WISE MANUFACTURERS, MANUFACTURING VOLUME & CONTACT OVERVIEW

10.1. Imipenem/Cilastatin Continent Wise Manufacturers
10.2. Imipenem/Cilastatin Continent Wise Manufacturing Volume
10.3. Imipenem/Cilastatin Country Wise Manufacturers
10.4. Imipenem/Cilastatin Country Wise Manufacturing Volume
10.5. Imipenem/Cilastatin Manufacturers Contact Overview

CHAPTER 11 IMIPENEM/CILASTATIN GLOBAL PRICE TREND ANALYSIS OF LAST 3 YEARS

11.1. Imipenem/Cilastatin Global Price Trend Analysis
11.2. Imipenem/Cilastatin Country Wise Price Trend Analysis

CHAPTER 12 IMIPENEM/CILASTATIN INTERNATIONAL MARKET OVERVIEW

12.1. Global Demand/ Supply & Global Prices
12.2. Major Destinations Involved In Trade
12.3. Major Manufacturers (Capacities & Prices)

CHAPTER 13 IMIPENEM/CILASTATIN (FORMULATION) GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2018-2023) ANALYSIS

13.1. Imipenem/Cilastatin Global Market Size (Past & Future Forecasting)
13.2. Imipenem/Cilastatin Global Market Growth (Past & Future Forecasting)
13.3. Imipenem/Cilastatin Continent Wise Market Size (Past & Future Forecasting)
13.4. Imipenem/Cilastatin Continent Wise Market Growth (Past & Future Forecasting)

CHAPTER 14 IMIPENEM/CILASTATIN (FORMULATION) CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW

14.1. Imipenem/Cilastatin Global Consumers
14.2. Imipenem/Cilastatin Global Consumers As Per Consumption Quantity
14.3. Imipenem/Cilastatin Continent Wise Consumer
14.4. Imipenem/Cilastatin Continent Wise Consumer As Per Consumption Quantity
14.5. Imipenem/Cilastatin Country Wise Consumer
14.6. Imipenem/Cilastatin Country Wise Consumer As Per Consumption Quantity
14.7. Imipenem/Cilastatin Consumers Contact Overview

CHAPTER 15 IMIPENEM/CILASTATIN (API) CONTINENT WISE EXPORT/ IMPORT ANALYSIS

15.1. Imipenem/Cilastatin (API) Continent Wise Import Analysis
15.2. Imipenem/Cilastatin (API) Continent Wise Export Analysis
15.3. Imipenem/Cilastatin (API) Country Wise Import Analysis
15.4. Imipenem/Cilastatin (API) Country Wise Export Analysis

CHAPTER 16 IMIPENEM/CILASTATIN (FORMULATION) CONTINENT WISE EXPORT/ IMPORT ANALYSIS

16.1. Imipenem/Cilastatin (Formulation) Continent Wise Import Analysis
16.2. Imipenem/Cilastatin (Formulation) Continent Wise Export Analysis
16.3. Imipenem/Cilastatin (Formulation) Country Wise Import Analysis
16.4. Imipenem/Cilastatin (Formulation) Country Wise Export Analysis

CHAPTER 17 IMIPENEM/CILASTATIN WORLDWIDE SWOT ANALYSIS

17.1. Imipenem/Cilastatin Strength Analysis
17.2. Imipenem/Cilastatin Weakness Analysis
17.3. Imipenem/Cilastatin Opportunity Analysis
17.4. Imipenem/Cilastatin Threat Analysis

CHAPTER 18 IMIPENEM/CILASTATIN REPORT BASED BUSINESS RECOMMENDATION

List Of Tables

LIST OF TABLES

Table 1: Route of Administration
Table 2: Available Composition of Imipenem/Cilastatin
Table 3: Dosage Representation Depending Upon Infection Severity
Table 4: Raw Material Required for 1000 Mg Injection
Table 5: List of Manufacturing Equipment Required
Table 6: List of Global Brand With Strength & Dosage Type
Table 7: Country Wise API Asian Market Overview
Table 8: Country Wise Formulation Asian Market Overview
Table 9: Country Wise Formulation European Market Overview
Table 10: Country Wise Formulation South American Market Overview
Table 11: Country Wise Formulation North American Market Overview
Table 12: Country Wise Formulation Oceania Market Overview
Table 13: Global API Manufacturer Overview
Table 14: Country Wise Global API Manufacturer Market Overview
Table 15: API Manufacturer Deliverable Format
Table 16: Formulation Global Manufacturer Market Overview
Table 17: Formulation Manufacturer Deliverable Format
Table 18: API Continent & Country Wise 2015 Price Range Analysis
Table 19: API Continent & Country Wise 2016 Price Range Analysis
Table 20: API Continent & Country Wise 2017 Price Range Analysis
Table 21: API Continent & Country Wise 2018 (Jan to July) Price Range Analysis
Table 22: Formulation Continent & Country Wise 2015 Price Range Analysis
Table 23: Formulation Continent & Country Wise 2016 Price Range Analysis
Table 24: Formulation Continent & Country Wise 2017 Price Range Analysis
Table 25: Formulation Continent & Country Wise 2018 (Jan to July) Price Range Analysis
Table 26: List of Top 10 Manufacturer With Brand Name & Approximate Price
Table 27: Market Size in Terms of Volume (MTS) Analysis (2014-18)
Table 28: Market Size in Terms of Value (M USD) Analysis (2014-18)
Table 29: Market Size in Terms of Volume (MTS) Analysis (2018-23)
Table 30: Market Size in Terms of Value (M USD) Analysis (2018-23)
Table 31: Global Imipenem/Cilastatin Consumer Analysis
Table 32: Global Imipenem/Cilastatin Consumer Deliverable Format
Table 33: Global Imipenem/Cilastatin API Export Analysis (2017-18)
Table 34: Global Imipenem/Cilastatin API Import Analysis (2017-18)
Table 35: Global Imipenem/Cilastatin API Export-Import Analysis (2015-18)
Table 36: Global Imipenem/Cilastatin Continent Wise API Import Analysis (2015-18)
Table 37: Global Imipenem/Cilastatin Continent Wise API Export Analysis (2015-18)
Table 38: Global Imipenem/Cilastatin Country Wise API Import Analysis (2015-18)
Table 39: Global Imipenem/Cilastatin Country Wise API Export Analysis (2015-18)
Table 40: Global Imipenem/Cilastatin Importer Wise Import Analysis (2015-18)
Table 41: Global Imipenem/Cilastatin Exporter Wise Export Analysis (2015-18)
Table 42: Global Imipenem/Cilastatin Export Analysis (2017-18)
Table 43: Global Imipenem/Cilastatin Import Analysis (2017-18)
Table 44: Global Imipenem/Cilastatin Export-Import Analysis (2015-18)
Table 45: Global Imipenem/Cilastatin Import Analysis (2015-18)
Table 46: Global Imipenem/Cilastatin Export Analysis (2015-18)
Table 47: Global Imipenem/Cilastatin Country Wise Import Analysis (2015-18)
Table 48: Global Imipenem/Cilastatin Country Wise Export Analysis (2015-18)
Table 49: Global Imipenem/Cilastatin Importer Wise Import Analysis (2015-18)
Table 50: Global Imipenem/Cilastatin Exporter Wise Export Analysis (2015-18)

LIST OF FIGURE

Figure 1: Imipenem/Cilastatin Structure
Figure 2: Imipenem/Cilastatin Dosage Type
Figure 3: Imipenem/Cilastatin Upstream & Downstream Application Flow Chart
Figure 4: Imipenem/Cilastatin Mechanism of Action
Figure 5: Asian API Country Wise Market Overview
Figure 6: Asian Formulation Country Wise Market Overview
Figure 7: European Formulation Country Wise Market Overview
Figure 8: South American Formulation Country Wise Market Overview
Figure 9: Global Country Wise API Manufacturer
Figure 10: Global Country Wise API No. of Manufacturer Production Volume
Figure 11: Global Country Wise Top API Manufacturer With Production Analysis
Figure 12: Country Wise Market Share Analysis
Figure 13: Continent Wise Formulation No. of Manufacturer
Figure 14: Continent Wise Formulation Manufacturer Production Volume
Figure 15: Global Continent Wise Top Formulation Manufacturer With Production Analysis
Figure 16: Global Continent Wise Market Share Analysis
Figure 17: Global Demand Supply Overview Analysis
Figure 18: Global Continent Wise No. of Consumer
Figure 19: Global Continent Wise No. Consumption Volume
Figure 20: Global Continent Wise No. Top Consumer Analysis
Figure 21: Global Country Wise market Share Overview
Figure 22: Global Continent Wise API Export Overview
Figure 23: Global Continent Wise API Import Overview
Figure 24: Global Continent Wise API Export-Import (2015-2018) Overview
Figure 25: Global Continent Wise Formulation Export Overview
Figure 26: Global Continent Wise Formulation Import Overview
Figure 27: Global Continent Wise Formulation Export Import (2015-2018) Overview